Kindstar Globalgene Technology, Inc. executed an on-market repurchase of 34,000 ordinary shares on 16 September 2026, paying between HKD 0.92 and HKD 0.93 per share for a total consideration of approximately HKD 0.03 million. The volume-weighted average price was HKD 0.9225.

Following the transaction, Kindstar Global’s issued share capital (excluding treasury shares) fell marginally by 0.00329 % to 1.03 billion shares, while its treasury-share holding increased to 9.15 million shares. Total issued shares remain at 1.04 billion.

The repurchase forms part of the mandate approved on 5 June 2026, which authorises the company to buy back up to 103.43 million shares. To date, Kindstar Global has repurchased 2.09 million shares under this mandate, equivalent to 0.20 % of the company’s issued share count as of the mandate date.

As required under Hong Kong Stock Exchange regulations, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 16 October 2026.